Benzinga - by Lisa Levin, Benzinga Editor.
StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat results for its third quarter on Friday.
StoneCo posted adjusted earnings of 27 cents per share, beating market estimates of 22 cents per share. The company’s sales came in at $643.35 million versus expectations of $610.17 million.
StoneCo shares gained 6.3% to $11.40 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- SenesTech, Inc. (NASDAQ: SNES) shares rose 81.3% to $0.4341 in pre-market trading. SenesTech shares fell 31% on Friday after the company reported worse-than-expected third-quarter revenue results.
- Collective Audience, Inc. (NASDAQ: CAUD) shares surged 57.2% to $4.67 in pre-market trading after jumping around 30% on Friday.
- Tivic Health Systems, Inc. (NASDAQ: TIVC) shares rose 26.7% to $1.52 in pre-market trading. -Tivic Health Systems is expected to report financial results for the third quarter 2023 on Nov. 14, 2023.
- Cazoo Group Ltd (NYSE: CZOO) shares climbed 21.4% to $0.4250 in pre-market trading after falling 11% on Friday.
- Near Intelligence, Inc. (NASDAQ: NIR) shares rose 21.1% to $0.23 in pre-market trading after dipping 31% on Friday.
- LQR House Inc. (NASDAQ: LQR) rose 17% to $0.1053 in pre-market trading after gaining around 8% on Friday. The company announced the pricing of a $11 million public offering of 157,142,857 shares at $0.07 per share.
- Dogness (International) Corporation (NASDAQ: DOGZ) rose 16.6% to $3.79 in pre-market trading.
- reAlpha Tech Corp. (NASDAQ: AIRE) shares rose 16.1% to $5.11 in pre-market trading after falling 11% on Friday.
- Prenetics Global Limited (NASDAQ: PRE) gained 12% to $0.3897 in pre-market trading after gaining around 5% on Friday.
- StoneCo (NASDAQ: MNPR) dipped 23.7% to $0.29 in pre-market trading after falling over 8% on Friday. Monopar Therapeutics, last week, posted a narrower-than-expected quarterly loss.
- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares fell 17% to $0.4898 in pre-market trading.
- Motus GI Holdings, Inc. (NASDAQ: MOTS) shares fell 15.4% to $3.37 in pre-market trading. Motus GI shares gained around 13% on Friday after the company announced the Pure-Vu EVS Gastro was successfully used in the first procedure since receiving FDA clearance.
- Safe and Green Development Corporation (NASDAQ: SGD) shares fell 14.3% to $0.5999 in pre-market trading after jumping 36% on Friday.
- Verve Therapeutics, Inc. (NASDAQ: VERV) shares fell 14.1% to $13.50 in pre-market trading after the company announced first human proof-of-concept data for in vivo base editing from the ongoing heart-1 phase 1b clinical trial of VERVE-101.
- Kodiak Sciences Inc. (NASDAQ: KOD) shares fell 14% to $1.48 in pre-market trading after declining 6% on Friday. Kodiak Sciences recently said its Phase 3 GLOW superiority study evaluating tarcocimab tedromer 5 mg in moderately severe to severe NPDR met its one-year primary endpoint.
- GlucoTrack, Inc. (NASDAQ: GCTK) shares fell 12.9% to $0.1376 in pre-market trading.
- Intelligent Bio Solutions Inc. (NASDAQ: INBS) fell 12.6% to $0.5044 in pre-market trading after surging around 32% on Friday.
- Intrusion Inc. (NASDAQ: INTZ) fell 12.3% to $0.42 in pre-market. The company announced that it entered into a Securities Purchase Agreement through a $2.4 million Private Offering of 4,359,374 shares at $0.60 per share.
- TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) fell 9.9% to $0.2075 in pre-market trading. TRACON Pharmaceuticals shares jumped 44% on Friday after the company reported third-quarter financial results.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.